SYRE earnings: a positive outcome, +23.4%

On April 13, 2026, Spyre Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +23.4% in the window around the event. It had already run +28.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.